Download free PDF

Smart Inhalers Market Size & Share 2023 to 2032

Market Size by Product (DPI-based Smart Inhalers, MDI-based Smart Inhalers), by Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce)– Global Forecast.

Report ID: GMI3994
   |
Published Date: October 2023
 | 
Report Format: PDF

Download Free PDF

Smart Inhalers Market Size

Smart Inhalers Market size was valued at USD 1.5 billion in 2022 and is estimated to account for USD 3.3 billion by 2032. Smart inhalers are sensor-enabled digital devices used for administration of drugs by inhalation as well as monitoring accurate doses and tracking inhaler usage.

Smart Inhalers Market Key Takeaways

Market Size & Growth

  • 2022 Market Size: USD 1.5 Billion
  • 2032 Forecast Market Size: USD 3.3 Billion
  • CAGR (2023–2032): 8.6%

Key Market Drivers

  • Growing prevalence of respiratory diseases across the globe.
  • Technological advancements in smart inhalers.
  • Increasing number of partnership agreements between pharma and software companies.
  • Increased medical adherence.

Challenges

  • Dearth of awareness in developing countries.
  • Significant security risks and privacy issues.

 

Rising prevalence of several chronic respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma is one of the major factors contributing to the market revenue. For instance, as per the European Academy of Allergy and Clinical Immunology (EAACI) in 2022, approximately 350 million people globally are currently suffering from asthma.

 

The integration of smart inhalers into telemedicine and remote patient monitoring devices, market of which being worth USD 14 billion in 2022, help to enhance patient care and also helps in managing respiratory conditions more effectively. It enables more timely interventions, reduces the need for in-person visits, and allows for a more personalized and patient-centered approach to healthcare. Thus, remotely monitoring and managing patients with respiratory conditions will positively influence the demand for smart inhalers.

 

COVID-19 Impact

The use of smart inhaler increased significantly during the COVID-19 pandemic. Rise in incidence rate of several respiratory complications among COVID-19 patients propelled the market demand. Moreover, a sudden upsurge in hospital admissions and patient visits associated with breathing problems led to an increased need for effective respiratory care thereby boosting market demand. Therefore, the continued adoption of smart inhalers throughout the pandemic further stimulated the market progress.
 

Smart Inhalers Market

Smart Inhalers Market Trends

Continuous technological advancements in smart inhalers are projected to accelerate the market growth. As smart inhaler is a part of the new-age digital technology, these devices are being optimized to enhance respiratory ailment management. Enhanced availability of advanced smart inhaler to treat respiratory diseases will fuel the market revenue size.
 

  • Advanced devices offer several benefits such as medication history tracker & monitoring, clinical data collection, enhanced accuracy, and ease of use compared to conventional inhalers thereby, accelerating the demand for therapeutic respiratory devices.

     
  • Furthermore, strong presence of key market players that are proactively involved in innovative product development and launches will fuel industry landscape.
     

Smart Inhalers Market Analysis

 Smart Inhalers Market Size, By Product, 2021 - 2032 (USD Billion)

The market by product is categorized into on DPI-based smart inhaler and MDI-based smart inhaler. The DPI- based smart inhalers segment garnered USD 959.4 million revenue size in the year 2022.

 

  • DPI-based smart inhaler is used to deliver specific dry powder medication to the lungs. This type of inhaler combines dry powder fluidization mechanism with unique real-time feedback and a data logger for indication of proper inhalation technique.
     
  • Moreover, several digital and pharmaceutical companies are focusing on advanced device development mechanisms and integration of add-on sensors thereby resulting in segment expansion.

 

Smart Inhalers Market Share, By Disease Indication, 2022

The smart inhalers market by disease indication is categorized into COPD and asthma. COPD held over 57% of industry share in 2022.

 

  • Growing prevalence of COPD will augment the market demand in upcoming years. Factors such as aging population base, continued exposure to risk factors such as tobacco smoke and air pollution, coupled with improved disease diagnosis contribute to a growing number of COPD patients. Hence, the factors listed above are projected to contribute towards market share.
     
  • For instance, as per Forum of International Respiratory Societies (FIRS) survey, COPD is the most prevalent non-communicable respiratory disease. An estimated two hundred million people have COPD and about 3.2 million die each year due to this condition, making it the third-leading cause of death worldwide.
     

The smart inhalers market by distribution channel is categorized into hospital pharmacies, retail pharmacies, and e-commerce. The hospital pharmacies segment accounted for considerable market revenue in 2022 and is estimated to proceed at an 8.3% CAGR during the projected timeframe.

 

  • Expanding infrastructure of hospital pharmacies in emerging markets will proliferate segment expansion. Moreover, easy accessibility to patients seeking treatment from the hospital is another factor contributing to revenue growth.
  •  
  • Product availability is another factor expected to increase the demand for smart inhalers in these settings. Hospital pharmacies are well connected with the smart inhaler distributors thereby positively influencing overall market trends.

 

U.S. Smart Inhalers Market Size, 2020 -2032 (USD Million)

U.S. smart inhalers market accounted for USD 520 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.

 

  • Technological advancements coupled with substantial healthcare expenditure are the factors driving the market progress. Increasing incidence of chronic respiratory diseases further stimulates the use of smart inhalers.
     
  • Major players in the industry are focusing on development of innovative product portfolio for respiratory disease treatment thereby creating new opportunities for the U.S. market size.
     

Smart Inhalers Market Share

The smart inhalers industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as Novartis holds a significant share in the market. The companies are diligently directing their efforts towards continuous product innovation and partnership with other players to gain substantial market share. For instance, Novartis collaborated with Propeller Health to connect the digital health platform to enerzair breezhaler in order to treat inadequately controlled asthma patients in Europe.

 

Some of the eminent market participants operating in the smart inhalers industry include:

  • Adherium
  • Propeller Health
  • Nemera
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Aptar Group Inc
  • AstraZeneca Plc
  • Findair Sp. Z.o.o.
  • BioCorp
  • Zeolr Technologies Pvt Ltd.
  • Vectura Group Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH

Smart Inhalers Industry News:

  • In August 2022, Adherium Limited collaborated with Trudell Medical Limited to offer service to COPD patient in the U.S. This collaboration helped both the companies to strengthen their portfolio.
     
  • In February 2022, AstraZeneca announced partnership with Honeywell in order to manufacture advanced respiratory inhalers using propellant HFO-1234ze. Propellant HFO-1234ze has around 99.9% less Global Warming Potential (GWP) as compared to the ones currently used in respiratory medicines. This product launch helped the company to enhance its product offerings in the significant market.
     

Smart inhalers market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

By Product, 2018-2032 (USD Million)

  • Dry powder inhaler (DPI)-based smart inhalers
  • Metered dose inhaler (MDI)-based smart inhalers

By Disease Indication, 2018-2032 (USD Million)

  • Asthma
  • Chronic obstructive pulmonary diseases

By Distribution Channel, 2018-2032 (USD Million)

  • Hospital pharmacies
  • Retail pharmacies
  • E-commerce

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

 

Authors:  Mariam Faizullabhoy, Gauri Wani

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the size of the Smart Inhalers Market?
The global smart inhalers industry size was USD 1.5 billion in 2022 and is estimated to account for USD 3.3 billion by 2032.
How is COPD influencing the smart inhalers industry growth?
COPD held over 57% industry share in 2022 and will augment the market demand by 2032 due to aging population base, rising disease prevalence caused by continued exposure to risk factors such as tobacco smoke and air pollution, coupled with improved disease diagnosis.
What are the factors driving the U.S. smart inhalers industry?
U.S. smart inhalers market accounted for USD 520 million in 2022 and is predicted to witness substantial growth through 2032 owing to technological advancements coupled with substantial healthcare expenditure.
Who are the key players in the global smart inhalers sector?
Adherium, Propeller Health, Nemera, GlaxoSmithKline Plc., Novartis AG, Aptar Group Inc, AstraZeneca Plc, Findair Sp. Z.o.o., BioCorp, Zeolr Technologies Pvt Ltd., Vectura Group Plc., Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim International GmbH.
Smart Inhalers Market Scope
  • Smart Inhalers Market Size

  • Smart Inhalers Market Trends

  • Smart Inhalers Market Analysis

  • Smart Inhalers Market Share

Authors:  Mariam Faizullabhoy, Gauri Wani
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 13

Tables & Figures: 192

Countries Covered: 16

Pages: 135

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)